Pharmaceutical

Diffusion Pharma’s stockholders support merger with EIP Pharma

The merger will be finalised today, transforming the businesses into a single company CervoMed focused on neurodegenerative diseases.

Aug 16, 2023 - 20:00
Diffusion Pharma’s stockholders support merger with EIP Pharma
The merger will be finalised today, transforming the businesses into a single company CervoMed focused on neurodegenerative diseases.
Read the original article

Tags:

Previous Article

FDA will not meet ahead of bluebird bio’s sickle cell disease gene therapy PDUFA...

Next Article

Eyenovia acquires US licencing rights for Formosa’s topical eye steroid

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Boehringer and CBmed partner to develop cancer therapies

Boehringer and CBmed partner to develop cancer therapies

Feb 10, 2024

‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs

‘Robbing Peter to pay Paul’: Obesity experts debate ris...

May 9, 2023

Silence announces $120m private placement for depositary shares

Silence announces $120m private placement for depositar...

Feb 6, 2024